In 2023, the import of medicaments mixed together for therapeutic use to Egypt stood at 29.62 million USD. Based on the provided forecast data from 2024 to 2028, there is a consistent year-on-year growth in imports, reflecting the increasing demand for these medicaments. For instance, from 2024 to 2025, the growth is approximately 2.6%, and this trend continues with the value reaching 33.41 million USD in 2028. The compound annual growth rate (CAGR) over the five-year forecasted period is projected to be around 2.5%.
Future trends to watch for include potential regulatory changes that could affect importing processes and prices. Additionally, advancements in medical technology and an increase in healthcare awareness could further bolster the demand. Monitoring global supply chain disruptions and their impacts on import prices will also be crucial.
